The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis
Clinical trial NCT07013838 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07013838
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-15
- Primary completion
- 2027-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.